Molecular Basis of Immunological Tolerance and Non-Response
Molecular Basis of Immunological Tolerance and Non-Response
批准号:
08044302
负责人:
SASAZUKI Takehiko
金额:
$5.76万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for international Scientific Research
财政年份:
1996
资助国家:
日本
项目状态:
已结题
起止时间:
1996 至 1998
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Immunological tolerance is established by elimination or inactivation of self-reactive T cells through TCR-MHC-peptide interaction in the thymus or periphery. To better understand the molecular mechanism for immunological tolerance, we focused on the generation of MHC/peptide complex and its recognition by TCRs, and obtained several new findings.We revealed that HLA-DM functions as an editor of MHC class II-binding peptides. This would raise the new possibility that the kinetic stability of MHC class II/peptide complex play a important role in tolerance induction. The development and analysis of transgenic-knockout mouse lines expressing a single MHC class IIIpeptide complex brought several new insights into T cells repertoire selection. In addition, we found that organ-specific autoimmunity spontaneously develops in one of such mouse lines, which would argue against the currently prevailing paradigm for MHC class II association with autoimmune diseases.
期刊论文(28)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Kropshofer H.: "Editing of the HLA-DR-peptide repertoire by HLA-DM." EMBO J.15. 9724-9729 (1996)
Kropshofer H.:“HLA-DM 编辑 HLA-DR 肽库。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Alferink J,et al.: "Control of neonatal tolerance to tissue antigens by peripheral T cell trafficking." Science.282. 1338-1341 (1998)
Alferink J 等人:“通过外周 T 细胞运输控制新生儿对组织抗原的耐受性。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Tamai H,et al.: "Association between the DRB1^*08032 histocompatibility antigen and methimazole-induced agranulocytosis in Japanese patients with Graves Disease." Annals of Internal Medicine. 124. 490-494 (1996)
Tamai H 等人:“DRB1^*08032 组织相容性抗原与日本格雷夫斯病患者中甲硫咪唑诱导的粒细胞缺乏症之间的关联。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hori T.: "Japanese cedar pollinosis and HLA-DP5" Tissue Antigens. 47. 485-491 (1996)
Hori T.:“日本雪松花粉病和 HLA-DP5”组织抗原。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ono T,et al.: "Molecular analysis of HLA class I(HLA-A and -B) and HLA class II(HLA-DRB1) genes in Japanese patients with multiple sclerosis(Western type and Asian type)." Tissue Antigens. 52. 539-542 (1998)
Ono T,et al.:“日本多发性硬化症患者(西方型和亚洲型)HLA I 类(HLA-A 和 -B)和 HLA II 类(HLA-DRB1)基因的分子分析”。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 27 条
Immunogenetic Analysis of Autoimmune Thyroid Diseases
-
批准号:17019069
-
项目类别:Grant-in-Aid for Scientific Research on Priority Areas
-
资助金额:$91.97万
-
财政年份:2005
-
负责人:SASAZUKI Takehiko
-
依托单位:
Mechanisms of oncogenesis and anti-oncogenesis
-
批准号:11178101
-
项目类别:Grant-in-Aid for Scientific Research on Priority Areas
-
资助金额:$186.43万
-
财政年份:1999
-
负责人:SASAZUKI Takehiko
-
依托单位:
Development of soluble TCR and soluble MHC/peptide compelx with high affinity for their ligands
-
批准号:08557026
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$7.68万
-
财政年份:1996
-
负责人:SASAZUKI Takehiko
-
依托单位:
in vitro manipulation of genes relevant to oncogenesis
-
批准号:06454608
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$4.48万
-
财政年份:1994
-
负责人:SASAZUKI Takehiko
-
依托单位:
Molecular mechanism of immune regulation and immune tolerance
-
批准号:05272103
-
项目类别:Grant-in-Aid for Scientific Research on Priority Areas
-
资助金额:$32.64万
-
财政年份:1993
-
负责人:SASAZUKI Takehiko
-
依托单位:
Molecular mechanisms of immune regulation.
-
批准号:05272104
-
项目类别:Grant-in-Aid for Scientific Research on Priority Areas
-
资助金额:$158.14万
-
财政年份:1993
-
负责人:SASAZUKI Takehiko
-
依托单位:
Molecular mechanism of immune response requlated by HLA
-
批准号:05044177
-
项目类别:Grant-in-Aid for international Scientific Research
-
资助金额:$8.32万
-
财政年份:1993
-
负责人:SASAZUKI Takehiko
-
依托单位:
Development of HLA bound peptitides which have supressive activity.
-
批准号:04557027
-
项目类别:Grant-in-Aid for Developmental Scientific Research (B)
-
资助金额:$12.1万
-
财政年份:1992
-
负责人:SASAZUKI Takehiko
-
依托单位:
Research on the molecular basis for genetic control of immune response in human
-
批准号:03404026
-
项目类别:Grant-in-Aid for General Scientific Research (A)
-
资助金额:$17.92万
-
财政年份:1991
-
负责人:SASAZUKI Takehiko
-
依托单位:
Molecular Analyses of the Genetic Control of Immune Response in Humans
-
批准号:63440028
-
项目类别:Grant-in-Aid for General Scientific Research (A)
-
资助金额:$19.39万
-
财政年份:1988
-
负责人:SASAZUKI Takehiko
-
依托单位:
The analysis of HLA-linked immune suppression genes and their expression.
-
批准号:60480177
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$4.35万
-
财政年份:1985
-
负责人:SASAZUKI Takehiko
-
依托单位:
国内基金
海外基金
登录
查看更多内容
MHC-I/CD14介导CD8+T细胞免疫抑制促进去势抵抗前列腺癌免疫逃逸的研究
-
批准号:2026JJ50277
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:钟上伟
-
依托单位:
去泛素化酶USP9X调控抗原呈递分子MHC-I的机制研究
-
批准号:JCZRQNB202600282
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
西黄丸通过m6A修饰介导YTHDF2/FAM13A/STUB1轴调控PCSK9-MHC-I信号逆转乳腺癌免疫逃逸的机制研究
-
批准号:2026JJ30083
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:谢小兵
-
依托单位:
BCAT2调控氨基酸代谢重编程抑制MHC-I类分子组蛋白乙酰化修饰协助免疫逃逸的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:蔡智勇
-
依托单位:
雷公藤衍生物LLDT-8通过调控NLRC5/MHC-I信号通路治疗多发性肌炎的机制研究
-
批准号:JCZRYB202500090
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
短程放疗通过IFN-β-CXCR3/MHC-II轴协同直肠癌化疗免疫治疗的分子机制研究
-
批准号:JCZRLH202500227
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
前纤维蛋白1促进MHC-I自噬性降解导致非小细胞肺癌免疫治疗耐药的机制研究
-
批准号:2025JJ50555
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:卢义晨
-
依托单位:
MHC-E限制性CD8+调节性T细胞抑制抗肿
瘤免疫反应的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:王蕾
-
依托单位:
基于ILF3-DNMT1-MHC-I途径诱导免疫逃逸探讨骨肉瘤免疫检查点抑制剂治疗原发耐药的分子机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:邹华
-
依托单位:
肿瘤相关成纤维细胞通过CNOT4/MHC-I通
路介导胰腺癌免疫逃逸的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:练国达
-
依托单位: